BOSTON – (February 2, 2016) – Joslin Diabetes Center, the world-renowned diabetes expert, has appointed John A. Perry, CFRE, a skilled fundraising professional with extensive experience in healthcare philanthropy, as Chief Development Officer effective February 1.

Mr. Perry’s three decades of fundraising experience includes 15 years within the medical and healthcare sectors. His previous appointment was at Brown University’s Warren Alpert Medical School, where he was Senior Associate Dean for Medical Advancement, serving as the Chief Advancement Officer in charge of philanthropy, stewardship, and alumni and parent relations for the medical school.

Prior to joining Brown in 2010, Mr. Perry served as Director of Development for the Department of Internal Medicine at the University of Michigan; Chief Development Officer at the Oakwood Healthcare System in Dearborn, Michigan; and Director of Major Gifts at the Karmanos Cancer Institute in Detroit Michigan.  

“The Joslin community, which consists of dedicated patients, families, caregivers, clinicians, researchers and donors, share a passionate commitment to be the preeminent institution in the fight against diabetes,” said Mr. Perry. “It is a privilege and honor for me to join in this fight and commit to a significant growth in philanthropic resources necessary to fund this vital mission.”

A Certified Fundraising Executive (CFRE), Mr. Perry holds a BA in Psychology from DePauw University and a Master of Science in Administration from Central Michigan University.  Mr. Perry has been active in the Association for Healthcare Philanthropy and served as chair for the AHP’s Midwest Regional Conference and as a member of the Midwest Regional Board. 

“Fundraising is critically important to Joslin’s ability to sustain our high level of care and research,” said Peter S. Amenta, M.D., Ph.D., President and CEO of Joslin Diabetes Center.  “We are all looking forward to working with John and to make his efforts successful.”

###

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment